The global Dextroamphetamine Sulfate API market was valued at US$ 60.1 million in 2024 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 3.9%, reaching US$ 81.2 million by 2032.The increasing prevalence of ADHD among children and adults, along with rising awareness about mental health treatment, is driving this growth.The Dextroamphetamine Sulfate API market refers to the indust..